Skip to content

JOVAPHAR

Active Private limited companyfounded 2024active for 2 yearsJean Van Hinsberghstraat 16A, 8430 MiddelkerkeKBO/BCE: BE 1011.149.279

Lifetime

1 annual account with figures
peak of €42,888 in 2025
€42,888 
peak of €5,721 in 2025
€5,721 
peak of €6,721 in 2025
€6,721 
€148,082 
Board1 name since 2024
1 director
Documentsfilings and deeds
14-07-202617 days before the deadline
2025micro format
First year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €190,000 estimated

The micro format states no turnover.

Debts

€148,082 96% of the balance sheet
Financial debts 79%Taxes and wages 4%Other 16%

Of this, €30,402 falls due within a year.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,136 companies had the same profile as JOVAPHAR has now. Each dot stands for 6 companies, two years later.

92.0%
were still trading
2.3%
stopped another way
5.2%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit under 5% of the balance sheet

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,136 companies, not a prediction for JOVAPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 08-07-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1011149279
Incorporation Founding capital of €1,000, 100 shares · Founded by (comparant,oprichter) · appointed as director · published on 08-07-2024 · Gazette deed
All 4 events

Comparable companies

same main activity, similar in size and age
Company
JOVAPHAR Middelkerke €154,803 €42,888 4.3% -
MONTPHARMA Forest €135,487 €55,087 82.3% -
NOVAPLEX Modave €119,122 €52,898 77.1% -
O.Sabur Genk €129,423 €57,943 57.1% -
PHARMACIE KLIPVELD Uccle €168,665 €64,720 27.8% -
FELIS PHARMA Oosterzele €133,809 €42,553 86.3% -
KARBON PLUS Diksmuide €127,790 €52,214 80.4% -

These companies have the same main activity as JOVAPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €119,000 and €169,000, founded between 2022 and 2024.

Official details

Source: KBO
Status
Active since 04-07-2024Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.361.259.7168430 Middelkerke, since 04-07-2024
Financial year end
31 December
Peppol
Reachable since 06-06-2025
Company details

Annual accounts 2025

€154,803
Filing
Filed on 14-07-2026, 17 days before the end of the filing period
Financials

Insights on JOVAPHAR

The 2025 annual accounts show equity of €6,721 and a net result of €5,721. Its solvency ranks better than 25% of 25,388 sector peers (NACE 47) in financial year 2025.

The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about JOVAPHAR

What is the company number of JOVAPHAR?
The company number of JOVAPHAR is 1011.149.279. The VAT number is the same number with BE in front: BE 1011.149.279.
Where is JOVAPHAR based?
The registered office is at Jean Van Hinsberghstraat 16A, 8430 Middelkerke.Company details
What does JOVAPHAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of JOVAPHAR?
JOVAPHAR is a private limited company (BV).
When was JOVAPHAR founded?
JOVAPHAR was founded on 04-07-2024.
Is JOVAPHAR still active?
Yes, JOVAPHAR is an active enterprise in the KBO register.
What is the turnover of JOVAPHAR?
The turnover in financial year 2025 is about €190,000. This figure is estimated from the gross margin of €42,888 and 56 comparable companies (NACE 477). It probably lies between €110,000 and €350,000.Financials
Is JOVAPHAR profitable?
In financial year 2025, JOVAPHAR made a profit of €5,721.
Where can I find the annual accounts of JOVAPHAR?
JOVAPHAR filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.